miocamen
a. menarini industrie farmaceutiche riunite s.r.l. via sette santi 3, 50131, florence, italy - midecamycin - coated tablet - midecamycin 600 mg - antibacterials for systemic use
miocamen
a. menarini industrie farmaceutiche riunite s.r.l. via sette santi 3, 50131, florence, italy - midecamycin - granules for oral suspension - midecamycin 50 mg/ml - antibacterials for systemic use
fastum 2.5% gel
a. menarini industrie farmaceutiche riunite s.r.l. via sette santi 3, 50131, florence, italy - ketoprofen - gel - ketoprofen 2.5 % (w/w) - topical products for joint and muscular pain
fastum 2.5% gel
a. menarini industrie farmaceutiche riunite s.r.l. via sette santi 3, 50131, florence, italy - ketoprofen - gel - ketoprofen 2.5 % (w/w) - topical products for joint and muscular pain
lioton 100,000 i.u./100 g gel
a. menarini industrie farmaceutiche riunite s.r.l. via sette santi 3, 50131, florence, italy - heparin sodium - gel - heparin sodium 2.5 iu/g - vasoprotectives
spasmomen 40mg film-coated tablets
a. menarini industrie farmaceutiche riunite s.r.l. via sette santi 3, 50131, florence, italy - otilonium bromide - film-coated tablet - otilonium bromide 40 mg - drugs for functional gastrointestinal disorders
fastum 2.5% w/w gel
a. menarini industrie farmaceutische riunite s.r.l. - ketoprofen - gel - 2.5 percent weight/weight - antiinflammatory preparations, non-steroids for topical use; ketoprofen
menarini silicon biosystems cellsearch circulating tumor cell kit (epithelial)
a. menarini asia-pacific holdings pte. ltd. - pathology - the cellsearch® circulating tumor cell kit is intended for the enumeration of circulating tumor cells (ctc) of epithelial origin (cd45-, epcam+, and cytokeratins 8, 18+, and/or 19+) in whole blood. the presence of ctc in the peripheral blood, as detected by the cellsearch® circulating tumor cell kit, is associated with decreased progression free survival and decreased overall survival in patients treated for metastatic breast, colorectal or prostate cancer. the test is to be used as an aid in the monitoring of patients with metastatic breast, colorectal or prostate cancer. serial testing for ctc should be used in conjunction with other clinical methods for monitoring metastatic breast, colorectal and prostate cancer. evaluation of ctc at any time during the course of disease allows assessment of patient prognosis and is predictive of progression free survival and overall survival.
quofenix
a. menarini industrie farmaceutiche riunite s.r.l. - delafloxacin meglumine - community-acquired infections - antibacterials for systemic use, - quofenix is indicated for the treatment of the following infections in adults:acute bacterial skin and skin structure infections (absssi),community-acquired pneumonia (cap), when it is considered inappropriate to use other antibacterial agents that are commonly recommended for the initial treatment of these infections (see sections 4.4 and 5.1).consideration should be given to official guidance on the appropriate use of antibacterial agents.
powergel 2.5% gel
a. menarini farmaceutica internazionale srl - ketoprofen - cutaneous gel - 25mg/1gram